0 items USD 0.00Search
- Did you mean
- current partners nova nordic partners 2029 2024
Your search for "current partnering novo nordisk partnering 2009 2014" gave back 580670 results.
The global Vasomotor Symptoms Treatment market was valued at US$ 8810 million in 2022 and is anticipated to reach US$ 12400 million by 2029,...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Vasomotor Symptoms Treatment market size is expected to reach $ 12570 million by 2029, rising at a market growth of 4.8% CAGR during the...
Catalog:
GIR
June 2023
Price: USD 4,480.00
The global Vasomotor Symptoms Treatment market size is projected to grow from US$ 8618.4 million in 2022 to US$ 12280 million in 2029; it is expected...
Catalog:
LPI
June 2023
Price: USD 3,660.00
According to our (Global Info Research) latest study, the global Vasomotor Symptoms Treatment market size was valued at USD 9065 million in 2022 and...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The global Long-acting GLP-1RA market size was valued at US$ 17220 million in 2022. With growing demand in downstream market, the Long-acting GLP-1RA...
Catalog:
LPI
December 2023
Price: USD 3,660.00
Semaglutide (trade names Rybelsus, Ozempic) is a medication for the treatment of type 2 diabetes. Side effects include medullary thyroid cancer,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global GLP-1R Agonist market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
The global GLP-1 Receptor Agonists market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2...
Catalog:
MRRPB5
April 2024
Price: USD 2,900.00
Glucagon-likepeptide-1 (GLP-1) is a hormone secreted by intestinal L cells. Its receptor (GLP-1R) is widely distributed in the central nervous system...
Catalog:
MRRPB5
April 2024
Price: USD 2,900.00
Recombinant human coagulation factor VIIa is a drug from Novo Nordisk for bleeding episodes and prevention of bleeding during surgical procedures or...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
